Pfizer Inc. 2022-04-13 Health serious FDA
Health · FDA · Recall #FDA-D-0759-2022
quinapril HCl/hydrochlorothiazide tablets, 20 mg/12.5 mg*, 90 Tablets bottles, Rx Only,… Recall
Issued April 13, 2022 · Pfizer Inc.
In April 2022, Pfizer Inc. recalled the quinapril HCl/hydrochlorothiazide tablets, 20 mg/12.5 mg*, 90 Tablets bottles, Rx Only,…, a serious health recall reported by the FDA.
Compiled by Maya Ellison, RecallCheckr
What this means for you
CGMP Deviations: N-nitroso-quinapril and N-nitroso-hydrochlorothiazide impurity above the acceptable daily intake limit.
What you should do
- 1 Stop using quinapril HCl/hydrochlorothiazide tablets, 20 mg/12.5 mg*, 90 Tablets bottles, Rx Only,… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Pfizer Inc. to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Pfizer Inc.
- Category
- Health
- Recall date
- April 13, 2022
- Units affected
- Not reported
- Sold at
- Nationwide
- Recall number
- FDA-D-0759-2022
- Made in
- United States
- Issuing agency
- FDA
In context
- Pfizer Inc. has 13 recalls in our database, including 5 rated Critical.
- We're tracking 3,576 Health recalls in our database.
- This is the 870th Health recall we've logged in 2022.